Table 1:
Background Characteristics and Injection Drug Use Behaviors and Practices by Subcutaneous Injection (Skin Pop).
| SKIN POPPED? | ||||
|---|---|---|---|---|
| Sample (n = 252) | No (n = 108) | Yes (n = 144) | p = a | |
| Age | 37.9 (± 10.7) | 38.6 (± 11.0) | 37.4 (± 10.7) | .381 |
| Sex (Male) | 147 (58.3%) | 66 (66.1%) | 81 (56.2%) | .439 |
| Race | ||||
| White | 150 (59.5%) | 58 (53.7%) | 92 (63.9%) | |
| Black | 52 (20.6%) | 26 (24.1%) | 26 (18.1%) | .259 |
| Other | 50 (19.8%) | 24 (22.2%) | 26 (18.1%) | |
| Latinx (Yes) | 40 (15.9%) | 18 (16.7%) | 22 (15.3%) | .765 |
| Yrs Education | 11.6 (± 2.25) | 11.3 (± 2.63) | 11.8 (± 2.25) | .145 |
| HIV Positive (Yes) | 33 (13.2%) | 19 (17.6%) | 14 (9.8%) | .070 |
| Ever HCV (Yes) | 242 (96.8%) | 103 (96.3%) | 138 (97.2%) | .683 |
| Primary IDU Drug (Opioids) | 227 (90.1%) | 96 (88.9%) | 131 (91.0%) | .584 |
| Age Initiated IDU | 25.8 (± 9.6) | 25.7 (± 10.4) | 26.0 (± 9.0) | .804 |
| # SSTIs (Past Year) | 1.54 (± 2.31) | 0.96 (± 1.51) | 1.98 (± 2.68) | <.001 |
| Intramuscular Injection (Yes) | 43 (17.1%) | 10 (9.3%) | 33 (23.0%) | .004 |
| Knowledge of subcutaneous injection risk | 133 (53.0%) | 51 (47.25%) | 82 (57.3%) | .112 |
a
P-value for t-test for differences in means or Pearson χ2 – test of independence.